CAD and TAVI

Anchorperson: D. W. Park

Spokesperson: M. Saji

Summary

What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of coronary sinus sequestration.

Learning Objectives

To understand clinical impact of CAD in TAVR recepients
To determine optimal CAD assessment (CT, CAG, FFR or iFR) in TAVR recepients
To timing of coronary revascularisation pre-TAVR and coronary access for future revascularisation post-TAVR
To understand exact assessment and treatment of coronary sinus sequestration

Presentations available when logged in:

Case 1 - Combined intermediate CAD (DS 50-70%): treat or not treat (FFR, iFR, QFR or others)
Case 2 – Borderline age (75 years), combined single-vessel (proximal LAD) disease: optimal treatment strategy of TAVR + PCI vs. SAVR + CABG
Case 3 – Post-TAVR sinus sequestration case: how can we exactly diagnose and how can we treat well?

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

CAD and TAVI

Learning Objectives

Log in or create account for free